Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinjo

Showing results (61-70 of 1,258) with videos related to

Pageof 126
Sort By:
Contemporary Clinical Trials Communications|April 27, 2018
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trialsShinjo Yada, Chikuma Hamada
International Journal of Molecular Sciences|December 5, 2014
Comparing biofouling control treatments for use on aquaculture netsGeoffrey Swain, Nagahiko Shinjo
Pharmaceutical Statistics|August 26, 2017
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycleShinjo Yada, Chikuma Hamada
Journal of Atherosclerosis and Thrombosis|October 25, 2023
Grasp of Fate: Determining the Prognosis of Plaque Erosion?Shinjo Sonoda, Koichi Node
Advanced Drug Delivery Reviews|October 24, 2015
Targeting cancer epigenetics: Linking basic biology to clinical medicineKeiko Shinjo, Yutaka Kondo
Ryoikibetsu Shokogun Shirizu|February 24, 2001
[Pelger-Huët anomaly]K Shinjo, R Ohno
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Gabapentin mitigates neuropathic pain in cancer patients--a case report]Masakuni Okada, Takuya Shinjo
Pharmaceutical Statistics|August 17, 2018
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinationsShinjo Yada, Chikuma Hamada
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report]Takuya Shinjo, Masakuni Okada
Nihon Juigaku Zasshi. the Japanese Journal of Veterinary Science|June 1, 1984
Fimbriae and hemagglutination in the Bacteroides fragilis groupT Shinjo, H Kiyoyama
Pageof 126

Showing results (61-70 of 1,258) with videos related to

Sort By:
Pageof 126
Contemporary Clinical Trials Communications|April 27, 2018
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trialsShinjo Yada, Chikuma Hamada
International Journal of Molecular Sciences|December 5, 2014
Comparing biofouling control treatments for use on aquaculture netsGeoffrey Swain, Nagahiko Shinjo
Pharmaceutical Statistics|August 26, 2017
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycleShinjo Yada, Chikuma Hamada
Journal of Atherosclerosis and Thrombosis|October 25, 2023
Grasp of Fate: Determining the Prognosis of Plaque Erosion?Shinjo Sonoda, Koichi Node
Advanced Drug Delivery Reviews|October 24, 2015
Targeting cancer epigenetics: Linking basic biology to clinical medicineKeiko Shinjo, Yutaka Kondo
Ryoikibetsu Shokogun Shirizu|February 24, 2001
[Pelger-Huët anomaly]K Shinjo, R Ohno
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Gabapentin mitigates neuropathic pain in cancer patients--a case report]Masakuni Okada, Takuya Shinjo
Pharmaceutical Statistics|August 17, 2018
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinationsShinjo Yada, Chikuma Hamada
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report]Takuya Shinjo, Masakuni Okada
Nihon Juigaku Zasshi. the Japanese Journal of Veterinary Science|June 1, 1984
Fimbriae and hemagglutination in the Bacteroides fragilis groupT Shinjo, H Kiyoyama
Pageof 126